MCI has provided over $8 million in support of non-hormonal, reversible male contraceptive research and development to date.
Beginning with our first grant in 2017, Male Contraceptive Initiative has sought to meaningfully advance the research and development work in the field of male contraception. Through these efforts, we have helped ensure the body of knowledge around male contraception not only grows, but is readily available to the present and future research community. On this page, we highlight our past grants and the researchers they supported.
Vibliome Therapeutics - 2017 Discovery and Development Awardee
|
Vibliome TherapeuticsDr. Rob Goodwin is the CEO of Vibliome Therapeutics, a start-up that’s developing inhibitors of a kinase essential for male fertility. Vibliome was MCI’s first major grant, and has since brought in MCI Fellow Aaron Crapster to serve as a Principal Scientist.
|
Instituto de Biologia y Medicina Experimental - 2018 Seed Grant Awardee
|
Instituto de Biologia y Medicina ExperimentalDr. Patricia Cuasnicủ is a Senior Scientific Researcher from Argentina’s Instituto de Biologia y Medicina Experimental (IBYME-CONICET) in Buenos Aires. Patricia has been working in the field of male contraception since 1984, and has been a leader in the field, serving with a World Health Organization Task Force, CONRAD, and other organizations.
|
Monash University - 2018 Seed Grant Awardee
|
Monash UniversityDr. Sabatino Ventura is a Senior Lecturer at the Monash Institute of Pharmaceutical Sciences in Parkville, Australia, in Melbourne. Sab’s work focuses on smooth muscle contraction, and harnessing it in order to create a male contraceptive.
|
University of Nevada, Reno - 2018 Seed Grant Awardee
|
University of Nevada, RenoDr. Wei Yan, formerly of University of Nevada, Reno, is Professor of Medicine at UCLA where he focuses on the development and function of germ cells. Dr. Yan has published over 130 peer-reviewed research articles, and discovered a novel plant extract that could be utilized as a male contraceptive.
|
Revolution Contraceptives - 2019 Grantee
|
Revolution ContraceptivesDr. Linda Brent is the Executive Director of the Parsemus Foundation, and oversees the Vasalgel project run by Revolution Contraceptives. Their work seeks to bring a vas-occlusive, reversible method of contraception to users that could last for years.
|
FHI 360 - 2019 Grantee
|
FHI 360FHI 360 is an international nonprofit working to improve the health and well-being of people in the United States and around the world. Their focus on contraception includes development and access, but also the assessment of the acceptability and preferences of a variety of methods of contraception.
|
For Grant Seekers
Current funding opportunities from Male Contraceptive Initiative and others are available on our Funding page.
